Compare Align Technology, Inc. (ALGN) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Lennar Corporation — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Lennar Corporation trades at $84.27 (market cap $20.25B). The key difference: Lennar Corporation is the larger of the two by market cap, and Lennar Corporation pays a 2.37% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | LEN | |
|---|---|---|
Market Cap | $12.86B | $20.25B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $142.40 |
52-Week Low | $124.88 | $82.30 |
Enterprise Value | $11.92B | $24.13B |
Dividend Yield | — | 2.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Lennar Corporation (LEN) trades at $84.27, down 0.09% on the day, with the stock showing bearish technical signals despite trading near analyst consensus targets. The homebuilder faces margin pressure with net income declining from $4.6B in 2022 to $2.1B in 2025, though valuation metrics appear attractive with P/E of 13.2 and P/B of 0.9. Recent earnings have consistently missed expectations, with Q2 2026 results showing mixed performance amid challenging housing market conditions.
LEN presents a value opportunity with discounted valuations but faces significant headwinds from declining profitability and housing market volatility. The stock's outlook hinges on execution amid affordability pressures, with analyst consensus leaning bullish (46% buy ratings) but technical indicators suggesting caution. Key risks include ongoing margin compression and macroeconomic sensitivity to interest rates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
